Introduction
It is well known that the vascular endothelium plays an essential role in the regulation of hemostatic processes (1) . The major defence mechanisms that prevent inappropriate coagulation are found at the endothelial cell surface (2). The endothelium itself is known to produce procoagulant factors like von Willebrand factor, and anticoagulant factors such as heparan sulfate and thrombomodulin (TM) (3).
In diabetic patients, hematological alteration has been reported to be a potentiated cause of dysbalance between hemostatic factors in plasma and/or at the endothelial cell surface.
TM is a thrombin binding protein on the endothelial cell surface which directly inhibits the procoagulant activities of thrombin. This results in accelerated inhibition of formation and inactivation of thrombin by antithrombin (4-6). Diabetes is characterized by the formation of advanced glycation endproducts (AGEs). It has been shown that endothelial cell surface TM activity is inhibited by AGEs (7). In addition, circulating TM is considered to be a marker of endothelial cell damage, because of increased plasma levels of TM in diabetic patients with nephropathy (8). On the other hand, the relationship between diabetic retinopathy and TM levels remains controversial since an increase in plasma TM due to decreased renal clearance and/or the presence of diabetes-related atherosclerosis has been observed (9, 10). To our knowledge no other group has evaluated the relationship of plasma TM with hematological alterations, intima-media thickness (IMT) and plaque thickness assessed with high-resolution Bmode ultrasonography.
This study was designed to investigate a group of diabetic patients selected because of the presence of moderate to severe diabetic retinopathy, and to determine whether plasma TM could serve as a endothelial marker for vascular injury in diabetes with retinopathy, or to identify other possible factors including abnormalities in coagulation and atheroscrelosis which may be related to endothelial cell damage and which could provide a basis for therapeutic intervention in diabetics with microang iopathy.
Research Design and Methods
We studied 164 outpatients with type 2 diabetes mellitus and 72 normal subjects.
Informed consent was obtained from all subjects.
All of the patients were ambulatory and had a normal appetite.
Exclusion criteria were 1) hypertension for more than 3 years ; 2) clinical evidence of target-organ damage by arterial hypertension (stroke, coronary heart disease, heart failure, intercurrent illness) ; 3) renal failure ; 4) presence of liver cirrhosis, chronic lung disease, or renal disease ; 5) pregnancy or lactation ; 6) use of oral contraceptives ; 7) venous thrombosis or pulmonary embolism. Patients with a serum creatinine level above 1.1 mg/dl were excluded from the study, since in these patients an increase in thrombomodulin due to decreased renal clearance has been observed.
The duration of diabetes was defined as the period from the time that glycosuria was first detected until the time of examination for this study. Smokers were defined as those patients who were currently smoking. The body mass index was calculated as weight (in kilograms) divided by the square of height (in meters squared). The normal control subjects were age-and sex-matched with the patients.
Ultrasonographic scanning of the carotid arteries was performed with an echotomographic system (EUB-450, Hitachi Medico, Japan) with an electrical linear transducer (midfreqency of 7.5 MHz). The scanning of extracranial carotid arteries in the neck was conducted bilaterally at 3 different (anterior-oblique, lateral, and posterior-oblique) longitudinal projections and at the transvers projection, as reported previously. Intima-media thickening of the arterial wall was defined as IMT more than 1.0 mm in the common carotid arteries below the carotid bulb. Severity of carotid atherosclerosis was evaluated by plaque score. The plaque score, using the scoring method presented by Handa et al, was computed as the sum of the maximum thickness of the intima-media complex (plaque thickness) measured in millimeters of both sides of the carotid arteries (11).
The diabetic patients were divided into 4 groups according to the severity of retinopathy, assessed by ophthalmological evaluation as follows : Table 5 shows various factors in the 43 normoalbuminuric patients without intima-media thickening and plaque thickness assessed with high-resolution B-mode ultrasonography.
Those with a history of coronary artery disease, arteriosclerosis obliterans and stroke were excluded.
Plasma levels of TM, vWf : Ag, TAT, PIC were significantly higher in the patients with retinopathy than in those without retinopathy, but other hemostatic parameters did not differ between these two groups.
Multivariate analysis showed TM, PIC and TAT levels to be independent predictors of diabetic retinopathy (Table  6 ). Since the first report by Ishii and Majerus (20), increased plasma levels of TM have been reported in cases of diabetes mellitus, disseminated intravascular coagulation (DIC), pulmonary thromboembolism, acute respiratory distress syndrome, chronic renal failure, and acute hepatic failure (21, 22). In these reports, the mechanism for the increase in plasma thrombomodulin was thought to be related to endothelial cell damage.
It is not clear at present how endothelial cell damage actually takes place in diabetic patients.
We suspected that increased plasma thrombomodulin reflects endothelial cell damage in diabetic microangiopathy and that hypercoagulability might play an important role in the endothelial cell damage. To investigate this hypothesis, we studied the relationship between the plasma levels of TM, vWf : Ag (an indicator of endothelial cell damage), TAT (an indicator of in vivo generation of thrombin), PIC (an indicator of in vivo generation of plasmin), urinary albumin excretion rate (AER), intima-media thickness and plaque score of the common carotid artery assessed with high-resolution B-mode ultrasonography, and severity of diabetic retinopathy.
An absolute standard for endothelial damage is not available, so we used the plasma concentration of vWf : Ag as a measure of endothelial cell damage, because in vitro and in vivo data suggest vWf : Ag is released when endothelial cells are damaged (23, 24).
There was an overall increase in plasma TM in patients with diabetic retinopathy, and vWf : Ag showed a weak but significant positive correlation with these levels of TM. These findings indicate that plasma TM is not independent of the hitherto used endothelial marker. On the other hand, although plasma vWf : Ag tended to increase as diabetic retinopathy worsened, there were no significant differences in plasma vWf : Ag levels among the control subjects, the no diabetic retinopathy group and the simple retinopathy group. These findings indicate that plasma TM level is a more sensitive marker of endothelial cell damage, especially in the early stages of diabetic retinopathy, compared with plasma vWf : Ag . These results were possible because unlike vWf : Ag , plasma TM is not a marker of endothelial cell stimulation, and there is little leakage of TM from the endothelial cell surface membrane in the absence of endothelial injury (25-27). vWf : Ag is easily released from endothelial cells by the stimulating action of various agents such as catecholamines, vasopressin, and thrombin (28-30) and the circadian fluctuation of plasma vWf : Ag is very large.
There were no significance differences in HbAic, fasting blood glucose, plasma lipids and other markers of coagulation between the four diabetic groups , although the plasma levels of TM, vWf ; Ag, TAT and PIC were significantly increased in the diabetic patients compared with normal control subjects.
These results were obtained in Variables in equation
Variables not in equation thrombotic tendency in diabetic microangiopathies. Ross reported that injury to the endothelium is the initiating event in atherogenesis (32). In this study, plasma TM levels showed a positive correlation with IMT and plaque score assessed with high-resolution B-mode ultrasonography.
Therefore, intimal endothelium damage caused by development of advanced lesions of atherosclerosis may at least in part contribute to the increase of plasma TM levels.
In addition, because nephropathy and macroangiopathy are frequently seen in patients with retinopathy, the elevated TM in diabetic retinopathy may indicate the relationships of plasma TM with nephropathy or atherosclerosis.
Considering these possibilities, we determined plasma TM levels in the normoalbuminuric type 2 diabetic patients without intima-media thickening of the arterial wall and other diabetes-related organ damage. This observation suggested that the plasma levels of TM, vWf : Ag, TAT and PIC were significantly greater in the patients with retinopathy than in those without retinopathy. This significant elevation of the plasma TM in diabetic retinopathy may indicate the specific relationship between plasma TM and diabetic retinopathy.
TM has been found on the endothelium of arteries, veins, capillaries, and lymphatics in many organs. It has also been reported that TM reactivity is found in the choroidal vessel but not in the retinal vessel (33). Generalized endothelial cell damage and thrombotic tendency in patients with diabetic retinopathy may be the reason for the increases of plasma TM, vWf : Ag, TAT and PIC.
Although our data represent the results from a study of a small group of patients without any follow-up, we strongly suggest that plasma thrombomodulin should be taken into consideration as a sensitive indicator of endothelial damage present in diabetic retinopathy. 
